111 Inc (YI)
1.04
+0.01
(+0.97%)
USD |
NASDAQ |
Jun 25, 16:00
1.04
0.00 (0.00%)
After-Hours: 20:00
111 Revenue (Annual): 2.113B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 2.113B |
December 31, 2022 | 2.012B |
December 31, 2021 | 1.925B |
December 31, 2020 | 1.189B |
Date | Value |
---|---|
December 31, 2019 | 572.15M |
December 31, 2018 | 270.17M |
December 31, 2017 | 142.22M |
December 31, 2016 | 131.26M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
572.15M
Minimum
2019
2.113B
Maximum
2023
1.562B
Average
1.925B
Median
2021
Revenue (Annual) Benchmarks
Concord Medical Services Holdings Ltd | 75.97M |
Sinovac Biotech Ltd | 448.27M |
CASI Pharmaceuticals Inc | 33.88M |
Zai Lab Ltd | 266.72M |
Adagene Inc | 18.11M |